NASDAQ: SCIISc II Acquisition Corp Stock
$9.99+0.00 (+0%)
Updated Apr 27, 2026
SCII Price
$9.99
Fair Value Price
N/A
Market Cap
$248.73M
52 Week Low
$9.92
52 Week High
$10.20
P/E
999x
P/B
221.98x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$104.84k
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
154.46
Operating Cash Flow
-$249k
Beta
-0.09
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
SCII Overview
SC II Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in New York, New York.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SCII's potential to beat the market
- SCII doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
SCII
RankedUnranked of 36
RankedUnranked of 36
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $10.54 | C | |
| $11.15 | C | |
| $10.02 | C |
Be the first to know about important SCII news, forecast changes, insider trades & much more!
SCII News
Overview
Due Diligence Score
–
Industry Average (10)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SCII scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SCII is poor value based on its earnings relative to its share price (999x), compared to the US market average (35x)
P/E vs Market Valuation
SCII is good value based on its earnings relative to its share price (999x), compared to the US Shell Companies industry average (-57.31x)
P/E vs Industry Valuation
SCII is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more SCII due diligence checks available for Premium users.
Valuation
SCII price to earnings (PE)
For valuing profitable companies with steady earnings
Company
999x
Industry
-57.31x
Market
35x
SCII is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SCII is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
SCII price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
221.98x
Industry
30.33x
SCII is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SCII's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
SCII's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$174.2M
Liabilities
$173.1M
Debt to equity
154.46
SCII's short-term assets ($1.37M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SCII's long-term liabilities ($172.78M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SCII's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
SCII's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
SCII vs Shell Company Stocks
Sc II Acquisition Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.